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Bile Salts Modulate Expression of the CmeABC Multidrug Efflux Pump in
Campylobacter jejuni
Abstract
CmeABC, a multidrug efflux pump, is involved in the resistance of Campylobacter jejuni to a broad spectrum of
antimicrobial agents and is essential for Campylobacter colonization in animal intestine by mediating bile
resistance. Previously, we have shown that expression of this efflux pump is under the control of a
transcriptional repressor named CmeR. Inactivation of CmeR or mutation in the cmeABC promoter
(PcmeABC) region derepresses cmeABC, leading to overexpression of this efflux pump. However, it is unknown
if the expression of cmeABC can be conditionally induced by the substrates it extrudes. In this study, we
examined the expression of cmeABC in the presence of various antimicrobial compounds. Although the
majority of the antimicrobials tested did not affect the expression of cmeABC, bile salts drastically elevated the
expression of this efflux operon. The induction was observed with both conjugated and unconjugated bile
salts and was in a dose- and time-dependent manner. Experiments using surface plasmon resonance
demonstrated that bile salts inhibited the binding of CmeR to PcmeABC, suggesting that bile compounds are
inducing ligands of CmeR. The interaction between bile salts and CmeR likely triggers conformational
changes in CmeR, resulting in reduced binding affinity of CmeR to PcmeABC. Bile did not affect the
transcription of cmeR, indicating that altered expression of cmeR is not a factor in bile-induced overexpression
of cmeABC. In addition to the CmeR-dependent induction, some bile salts (e.g., taurocholate) also activated
the expression of cmeABC by a CmeR-independent pathway. Consistent with the elevated production of
CmeABC, the presence of bile salts in culture media resulted in increased resistance of Campylobacter to
multiple antimicrobials. These findings reveal a new mechanism that modulates the expression of cmeABC and
further support the notion that bile resistance is a natural function of CmeABC.
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CmeABC, a multidrug efflux pump, is involved in the resistance of Campylobacter jejuni to a broad spectrum
of antimicrobial agents and is essential for Campylobacter colonization in animal intestine by mediating bile
resistance. Previously, we have shown that expression of this efflux pump is under the control of a transcrip-
tional repressor named CmeR. Inactivation of CmeR or mutation in the cmeABC promoter (PcmeABC) region
derepresses cmeABC, leading to overexpression of this efflux pump. However, it is unknown if the expression
of cmeABC can be conditionally induced by the substrates it extrudes. In this study, we examined the expression
of cmeABC in the presence of various antimicrobial compounds. Although the majority of the antimicrobials
tested did not affect the expression of cmeABC, bile salts drastically elevated the expression of this efflux
operon. The induction was observed with both conjugated and unconjugated bile salts and was in a dose- and
time-dependent manner. Experiments using surface plasmon resonance demonstrated that bile salts inhibited
the binding of CmeR to PcmeABC, suggesting that bile compounds are inducing ligands of CmeR. The interaction
between bile salts and CmeR likely triggers conformational changes in CmeR, resulting in reduced binding
affinity of CmeR to PcmeABC. Bile did not affect the transcription of cmeR, indicating that altered expression of
cmeR is not a factor in bile-induced overexpression of cmeABC. In addition to the CmeR-dependent induction,
some bile salts (e.g., taurocholate) also activated the expression of cmeABC by a CmeR-independent pathway.
Consistent with the elevated production of CmeABC, the presence of bile salts in culture media resulted in
increased resistance of Campylobacter to multiple antimicrobials. These findings reveal a new mechanism that
modulates the expression of cmeABC and further support the notion that bile resistance is a natural function
of CmeABC.
Multidrug efflux systems (often named multidrug resistance
[MDR] pumps), particularly the efflux pumps belonging to the
resistance-nodulation-cell division (RND) superfamily, con-
tribute significantly to bacterial resistance to antimicrobial
compounds, including those (e.g., bile salts) naturally present
in animal hosts (12, 22, 36, 39). The expression of MDR efflux
pumps is usually modulated by transcriptional regulators (10),
many of which are local repressors that interact directly with
the promoters of the genes encoding efflux pumps. Mutations
in the repressors or repressor-binding sequences can result in
overexpression of efflux pumps, which can increase bacterial
resistance to structurally unrelated antimicrobial agents (10,
18, 36, 39). In addition to the mutation-based mechanisms that
result in sustained overexpression of MDR efflux pumps in
bacteria, the expression of some MDR efflux pumps can be
conditionally induced by the substrates of these pumps (10,
36). This induction is usually mediated by the direct interaction
of the substrates with repressor molecules, leading to reduced
binding of repressors to operator DNA and increased tran-
scription of efflux genes. Since sustained overexpression of
efflux pumps can be detrimental to bacterial fitness (7, 26),
conditional induction of efflux machineries by their substrates
provides bacterial pathogens with a cost-efficient mechanism
for rapid adaptation to environmental changes.
CmeABC is characterized as an RND-type MDR pump in
Campylobacter jejuni (21, 38), the leading bacterial cause of
food-borne enteritis in humans in many industrialized coun-
tries (9). As an enteric pathogen, Campylobacter has evolved
multiple mechanisms to adapt to the environment in the gas-
trointestinal tract as well as clinical antimicrobial treatments.
One of the major mechanisms utilized by C. jejuni for adapta-
tion is CmeABC, which is encoded by a three-gene operon and
acts synergistically with other mechanisms in conferring intrin-
sic and acquired resistance to structurally diverse antimicrobi-
als (21, 25, 38). Notably, CmeABC plays a key role in mediat-
ing bile resistance and is essential for Campylobacter growth in
bile-containing media and in animal intestinal tract, as evi-
denced by the inability of a cmeB null mutant to colonize
chickens (22). As an important efflux mechanism, cmeABC is
constitutively expressed at a moderate level in wild-type
Campylobacter strains cultured in conventional media (21, 34).
This moderate-level expression of cmeABC is controlled by a
transcriptional repressor named CmeR (19). CmeR is encoded
by the gene (named cmeR) located immediately upstream of
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cmeABC and is a member of the TetR family of transcriptional
regulators. Like the N-terminal region of other members in the
TetR family, the N-terminal region of CmeR contains a typical
DNA-binding -helix-turn--helix (HTH) motif, while the C-
terminal region is predicted to be involved in the interaction
with inducers. cmeR is transcribed in the same direction as
cmeABC, and the intergenic region between cmeR and cmeA
contains the promoter for cmeABC (PcmeABC). As a transcrip-
tional factor, CmeR directly binds to the inverted repeat in
PcmeABC and represses the transcription of cmeABC. Inactiva-
tion of CmeR or mutation in the promoter sequence impedes
the repression and leads to enhanced production of the MDR
efflux pump in C. jejuni (19).
Despite the recent progress in understanding the function
and regulation of CmeABC, it is not known if expression of
cmeABC is inducible by the substrates it extrudes. Given that
CmeABC plays a significant role in antimicrobial resistance
and Campylobacter colonization of the intestinal tract, induc-
ible expression of cmeABC may facilitate rapid adaptation of
Campylobacter to environmental changes. In this study, we
showed that most substrates of CmeABC, including various
antibiotics, did not affect cmeABC expression. However, both
conjugated and nonconjugated bile salts dramatically induced
the expression of cmeABC. This induction is mediated by in-
hibition of CmeR binding to PcmeABC as well as a CmeR-
independent activation pathway. These findings reveal a new
mechanism that modulates cmeABC expression in response to
the presence of bile in the environment and further support the
notion that bile resistance is the natural function of CmeABC.
MATERIALS AND METHODS
Bacterial strains, plasmids, and culture conditions. Various Campylobacter
strains, mutants, and plasmids used in this study and their sources are listed in
Table 1. These isolates were routinely grown in Mueller-Hinton (MH) broth
(Difco) or agar at 42°C under microaerobic conditions, which were generated
using a Campygene (Oxoid) gas pack in enclosed jars. When needed, MH media
were supplemented with kanamycin (30 g/ml), chloramphenicol (4 g/ml), or
various concentrations of bile salts.
Chemical compounds. The compounds used for the cmeABC induction assays
and the antimicrobial susceptibility tests were purchased from Sigma Chemical
Co. (norfloxacin, tetracycline, ampicillin, cefotaxime, rifampin, erythromycin,
fusidic acid, novobiocin, sodium salicylate, chloramphenicol, cholate, deoxy-
cholate, taurodeoxycholate, glycocholate, chenodeoxycholate, choleate, and tau-
rocholate), ICN Biomedicals, Inc. (ciprofloxacin), and AMRESCO (ethidium
bromide). All bile compounds are sodium salts, and their pH is approximately 7.0
after solubilization in MH broth. Choleate is a crude ox bile extract which
contains the sodium salts of taurocholic, glycocholic, deoxycholic, and cholic
acids.
Antimicrobial susceptibility tests. The MICs of different antimicrobials in C.
jejuni 81-176 were determined using a microtiter broth dilution method as de-
scribed in our previous publications (21, 22). To determine the effect of bile salts
on the susceptibility of C. jejuni 81-176 to other antimicrobials, MH broth was
supplemented with cholate or taurocholate to final concentrations of 1 mg/ml
and 25 mg/ml, respectively. The concentrations of the two bile salts were chosen
according to their known MICs in strain 81-176 (21, 22) and were sublethal (0.5
MICs) to Campylobacter growth. Three independent experiments were con-
ducted to confirm the reproducibility of the MIC data.
Construction of JL112. The cbrR mutant of C. jejuni F38011 (40) was provided
by Michael E. Konkel (Washington State University). Genomic DNA was ex-
tracted from the cbrR mutant and was used to transform JL110 (Table 1) by the
method of natural transformation as described by Wang and Taylor (50). This
transformation procedure introduced the cbrR null mutation into JL110, creating
mutant JL112 (Table 1). The cbrR mutation in JL112 was confirmed by PCR.
Assays of cmeABC transcription under different conditions. Transcription of
cmeABC was determined by measuring -galactosidase (LacZ) activity in the
Campylobacter strains harboring the PcmeABC-lacZ transcriptional fusion as de-
scribed in our previous study (19). Briefly, the strains containing the reporter
plasmid were grown for 16 h to log phase (absorbance at 600 nm, approximately
0.2) in MH broth with or without sublethal concentrations (0.5 MICs) of
antimicrobials, including bile salts. Campylobacter cultures were washed twice in
cold phosphate-buffered saline, and the -galactosidase in each culture was
measured as described by Miller (30). To determine if induction of cmeABC by
bile is time dependent, 100 ml of log-phase culture was equally divided into two
portions and inducer cholate was added into one part to a final concentration of
1 mg/ml. At different time points, 1 ml each of the induced and noninduced
cultures was taken for -galactosidase activity as described above. For each time
point, triplicate samples were collected for measurements. For measuring dose-
dependent induction, strain 81-176 was grown in MH broth with various con-
centrations (0, 0.125, 0.25, 0.5, 1, and 2 mg/ml) of cholate for 16 h, and then the
cells were collected for -galactosidase activity.
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot-
ting. To prepare whole cell lysates, C. jejuni 81-76 was grown to late log phase
(2  109 cells/ml) in MH broth without or with different concentrations (1 and
2 mg/ml) of cholate, harvested by centrifugation, and adjusted by using phos-
phate-buffered saline to the same absorbance (0.230) at 600 nm. Approximately
4  108 whole cells were loaded in each lane and separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis with a 12% (wt/vol) polyacrylamide
separating gel (17). Production of CmeB and CmeC was examined by immuno-
blotting using anti-CmeB and anti-CmeC antibodies as described previously (21).
Analysis of CmeR interaction with PcmeABC by SPR. Surface plasmon reso-
nance (SPR) is a refractometry-based technique that allows the measurement of
biomolecular interactions in real time as changes of mass concentrations on a
sensor surface (41). A Biacore 1000 (Biacore AB, Uppsala, Sweden) was used in
this study to examine the interaction of CmeR with PcmeABC in the presence or
absence of bile salts. Recombinant CmeR of strain 81-176 was produced in
Escherichia coli as described in a previously published work (19). DNA probes
corresponding to PcmeABC (nucleotides 100 to 1 upstream of the ATG start
codon of cmeA) and an internal cmeA gene fragment (nucleotides 217 to 316) of
strain 81-176 were synthesized by Sigma (St-Quentin-Fallavier, France). The
internal cmeA fragment was used as a negative control for nonspecific binding
(19). The probes were immobilized onto streptavidin-coated sensor chips, which
were supplied by Biacore AB (Uppsala, Sweden). Before immobilization, the
biosensor surface was washed three times by injecting 20 l of 1 M NaCl, 50 mM
NaOH at a flow rate of 20 l/min as indicated by the manufacturer. Immobili-
zation was performed at a flow rate of 5 l/min by using Tris-HCl (10 mM
Tris-HCl, 300 mM NaCl, 0.5 mM EDTA, pH 7.1) as the running buffer. First, a
5-biotinylated single-stranded promoter DNA or the control DNA was resus-
pended in the Tris-HCl buffer, denatured at 65°C for 2 min, and then injected
(0.62 g/ml, 35 l) onto the streptavidin-coated dextran. The predenatured
(65°C for 2 min) cDNA strand was subsequently injected (55 g/ml, 35 l).
Hybridization between the complementary strands formed double-stranded
DNA probes immobilized onto the sensor chip with a surface density of 700
resonance units (RU). Following the DNA immobilization, the coated surface
was washed by two injections (5 l) of regenerating buffer (10 mM Tris-HCl, 2
M NaCl, pH 8.0). The specific interaction of CmeR with the promoter DNA was
examined by injecting 30 l of recombinant CmeR at various concentrations (13
to 208 nM) in running buffer (10 mM Tris-HCl, 150 mM NaCl, 1 mM MgCl2, 0.5
TABLE 1. Bacterial plasmids and C. jejuni strains used in this study
Plasmid or
strain Description
Source or
reference
Plasmids
pMW10 E. coli-C. jejuni shuttle vector with
promoterless E. coli lacZ gene,
Kanr
51
pIT81 pMW10 derivative with the cmeABC
promoter of wild-type C. jejuni
81-176 inserted upstream of lacZ
19
Strains
81-176 Wild type; isolated from human 2
JL108 81-176 containing pMW10 19
JL110 81-176 containing pIT81 19
JL111 JL110 derivative; cmeR::cm 19
JL112 JL110 derivative; cbrR::cm This study
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mM EDTA, 0.005% P20, pH 8.0) at a flow rate of 20 l/min. Association was
monitored during sample injection, and dissociation was observed during wash-
ing with the running buffer.
Prior to the inhibition experiments with bile salts, injection of sodium choleate
in the concentration range (2 to 125 g/ml) was first tested alone to determine if
the bile salts affected the stability of DNA immobilized on the streptavidin-
coated sensor chips. In every case, the decrease of signals was less than 5 RU,
indicating that bile salts did not have a significant impact on the immobilized
DNA. Two distinct experiments to determine the effect of sodium choleate on
the binding of CmeR to PcmeABC were performed. In experiment 1, CmeR (104
nM) was incubated at 25°C for 5 min with sodium choleate at various concen-
trations (2 to 125 g/ml) before injection, while in experiment 2 various concen-
trations of sodium choleate (2 to 125 g/ml, 60 l) were injected after CmeR
(104 nM) bound to DNA. Each assay was also performed under the same
conditions on the control flow cell coated with the cmeA internal fragment for
nonspecific-binding subtraction. Kinetic data were analyzed using BIA evalua-
tion software (version 3.1). The calculated kinetic constants (kon and koff) were
validated with the chi-square test by using the 1:1 Langmuir model. The disso-
ciation constant (KD) is calculated as the ratio of koff/kon. Before analysis, all
binding curves were corrected for nonspecific background and bulk refractive
index by subtracting the reference curve obtained from the control flow cell.
Real-time quantitative RT-PCR analysis of cmeR transcription in the presence
of bile salts. C. jejuni 81-176 was grown in MH broth or MH broth with cholate
(final concentrations of 0.5, 1, and 2 mg/ml) for 16 h under microaerobic con-
ditions. At harvest, 2 volumes of RNAprotect bacterial reagent (QIAGEN,
Valencia, CA) were added to the cultures to stabilize total bacterial RNA and
the mixtures were incubated at room temperature for 5 min. Then, the bacterial
cells were collected by centrifugation at 5,000  g for 10 min. Total RNA in each
sample was isolated by using an RNasy mini kit (QIAGEN) according to the
manufacturer’s instructions. Isolated RNA was further treated with TURBO
DNA-free (Ambion) to remove DNA contamination. cmeR-specific primers (F3,
5-ATTTTCAATCAACCAGAAGCTG-3, and R3, 5-TCCAATTGGCAAGA
TGTCTATC-3) and primers specific for the Campylobacter 16S RNA gene
(16SF, 5-TACCTGGGCTTGATATCCTA-3, and 16SR, 5-GGACTTAACCC
AACATCTCA-3) were designed using the Primer3 online interface (http://
frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi). Each amplicon was analyzed
with the MFold server (http://www.bioinfo.rpi.edu/applications/mfold/old/rna/) to
avoid secondary RNA structures and hairpin loops. Before being used for quan-
titative reverse transcriptase PCR (RT-PCR), each RNA template and each
primer set were tested with a conventional one-step RT-PCR kit and a regular
PCR kit (Invitrogen) to ensure specific amplification from the target mRNA and
no detectable DNA contamination in the RNA preparation. For each RNA
template, to generate the standard curve for quantification of the target tran-
script, 10-fold dilution series between 2.5 pg and 25 ng were made for each RNA
template and used for RT-PCR with the MyiQ iCycler real-time PCR detection
system (Bio-Rad, CA). The RT-PCRs were conducted using the iScript one-step
RT-PCR kit with SYBR green (Bio-Rad). Triplicate reactions in a volume of 20
l were performed for each dilution of the RNA template. Thermal cycling
conditions were as follows: 10 min at 50°C, 5 min at 60°C followed by 5 min at
95°C, and then 40 cycles of 10 s at 95°C and 30 s at 55°C (for 16S RNA) or 58°C
(for cmeR). Melt-curve analysis was performed immediately following each am-
plification. Each specific amplicon was verified both by the presence of a single
melting temperature peak and by the presence of a single band of expected size
on a 3.5% agarose gel after electrophoresis. Control reactions with no RNA
template were conducted for each primer set to ensure the absence of nonspe-
cific-primer dimers. Samples were normalized using 16S RNA as an internal
standard. Cycle threshold values were determined with the MyiQ software (Bio-
Rad). The relative changes (n-fold) in cmeR transcription between the induced
and noninduced samples were calculated using the 2		CT method as described
by Livak and Schmittgen (23).
RESULTS
Induction of cmeABC expression by antimicrobials. To de-
termine if the expression of cmeABC can be conditionally
induced by the substrates that are extruded by the efflux pump,
we measured LacZ activities of strain JL110 (C. jejuni 81-176
containing PcmeABC-lacZ [Table 1]) grown in the presence or
absence of sublethal concentrations of antimicrobials. The
LacZ assay showed that transcription of cmeABC was not af-
fected by most of the tested substrates, including ethidium
bromide, ciprofloxacin, norfloxacin, tetracycline, cefotaxime,
rifampin, erythromycin, chloramphenicol, and salicylate (data
not shown). However, addition of various bile salts to MH
broth significantly induced the expression of cmeABC (Fig. 1).
Compared to the basal level of transcription in MH broth,
addition of various bile salts in the culture resulted in a 6- to
16-fold increase in the expression of cmeABC (Fig. 1A). The
magnitudes of increase (n-fold) in LacZ activity upon induc-
tion by bile salts were reproducible in two to five independent
experiments. Consistent with the increase in cmeABC tran-
scription, immunoblotting showed that the production levels of
CmeB and CmeC in cholate-containing media were substan-
tially higher than those in the noninduced culture (Fig. 1B).
Together, these results indicated that bile salts were strong
inducers for the transcription and expression of cmeABC.
Induction of cmeABC by bile salts was dose dependent and
time dependent. To determine the induction kinetics, the time
FIG. 1. Induction of cmeABC expression by bile salts in C. jejuni 81-176. (A) Effects of various bile salts on the transcription of cmeABC in
81-176, as measured by transcriptional fusion (JL110). For the LacZ assay, JL110 was grown in the absence (control) of bile salt or presence of
the following bile salts at the concentrations sublethal to Campylobacter: 2 mg/ml of cholate (CA), 2 mg/ml of deoxycholate (DOC), 2.5 mg/ml of
taurodeoxycholate (TDC), 5 mg/ml of glycocholate (GCA), 3 mg/ml of chenodeoxycholate (CDC), 25 mg/ml of taurocholate (TCA), and 2.5 mg/ml
of choleate. The bars represent the means 
 standard deviations of triplicate samples from a single representative experiment. (B) Immunoblot
analysis of CmeB and CmeC production in 81-176 grown in the absence (lane 2) or presence of cholate with final concentrations of 2 mg/ml (lane
3) and 1 mg/ml (lane 4). The same number of bacterial cells (based on optical density at 600 nm) was loaded in each lane. Prestained protein
molecular mass markers (Bio-Rad) are shown in lane 1. The positions of CmeB and CmeC are indicated by arrows. Two different blots,
immunostained with anti-CmeB (top) and anti-CmeC (bottom) antibodies, are shown.
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course and dose response of the induction were measured
using JL110 (Table 1). For measuring the dose-dependent
response, JL110 was grown in MH broth containing different
amounts of cholate for 16 h and then analyzed for LacZ ac-
tivity. As shown in Fig. 2A, the sublethal concentration (2
mg/ml) of cholate led to an approximately sevenfold increase
in LacZ activity over that of the noninduced culture. With a
decrease of cholate concentration in each culture medium, the
change in the transcription (n-fold) of cmeABC also declined
(Fig. 2A). However, as little as 0.125 g/ml of cholate in each
culture medium still resulted in an approximately twofold in-
duction in the transcription of cmeABC (Fig. 2A). The time
course of the induction was determined using 1 mg/ml of
cholate in MH broth, and the result is shown in Fig. 2B. A
significant increase in transcription was observed after a 2-h
incubation with cholate. Thereafter, the induction gradually
increased and reached approximately fourfold that of the non-
induced control after 6 h of growth. Further incubation up to
16 h yielded limited additional increase in transcription from
that with the 6-h induction. Since work conducted with E. coli
(42) and Salmonella enterica serovar Typhimurium (37) indi-
cated that the bacterial growth phase affected the transcription
level of acrAB (an RND-type efflux pump), we compared the
transcription levels of cmeABC in the log phase and stationary
phase by using JL110 in conventional MH broth, and the re-
sults from three independent experiments indicated that the
transcription rate of cmeABC did not change with the growth
phase (data not shown).
Bile salts interfere with CmeR binding to PcmeABC. CmeR
functions as a transcriptional repressor of cmeABC and binds
specifically to PcmeABC, inhibiting the expression of the efflux
operon (19). We hypothesized that bile salts interact directly
with CmeR, inhibiting the interaction between CmeR and
PcmeABC and leading to the increase in cmeABC expression. To
test this hypothesis, we determined the interaction between
CmeR and PcmeABC in the presence or absence of bile salts by
using SPR. Injection of the CmeR protein over a range of
concentrations (13 to 208 nM) showed a steady-state increase
in RU (data not shown), indicating the dose-dependent and
stable binding of CmeR to the immobilized promoter DNA.
This finding was consistent with the result obtained from the
gel mobility shift assay conducted in a previous study (19) and
further demonstrated the specific interaction between CmeR
and PcmeABC. As determined with BIA evaluation software, the
dissociation constant (KD) of CmeR to the promoter sequence
was 88 
 2 nM (2  1.95).
SPR experiments were repeated using the same sensor chip
and a constant concentration (104 nM) of CmeR, which was
preincubated for 5 min with various amounts of sodium
choleate (2 to 125 g/ml) prior to injection. The results showed
that when CmeR was exposed to increasing levels of sodium
choleate, the binding of CmeR to the DNA decreased drasti-
cally (Fig. 3A). When sodium choleate was injected after
CmeR bound to the immobilized PcmeABC promoter DNA, a
significant change in the dissociation rate of the CmeR-DNA
complex was observed (Fig. 3B), indicating that bile salts pro-
moted the dissociation of CmeR from the promoter DNA.
This effect was proportional to the concentration of sodium
choleate used (Fig. 3B). Together, the SPR results clearly
demonstrated that bile salts interfere with the binding of
CmeR to the promoter sequence of cmeABC, which is consis-
tent with the finding that bile salts induce the expression of
cmeABC in vivo (Fig. 1 and 2).
Bile salt does not affect the transcription of cmeR. To de-
termine if bile salt affects the expression of cmeR, the tran-
scription of cmeR in the presence of cholate (0.5, 1, and 2
mg/ml) was compared with that in the noninduced control by
using real-time quantitative RT-PCR. Results from three in-
dependent experiments did not reveal any significant changes
in the expression of cmeR in the presence of cholate (data not
shown), indicating that the expression of cmeR was not induced
or inhibited by bile salts. Thus, the enhanced expression of
cmeABC in the presence of bile salts cannot be explained by
the change in cmeR transcription.
CmeR-dependent and -independent induction. The results
from the SRP experiments (Fig. 3) strongly suggest that the
FIG. 2. Dose-dependent (A) and time-dependent (B) induction of the cmeABC operon by cholate. The data are presented as the ratios of LacZ
activity between JL110 with cholate and the same strain grown without bile salts. Each bar represents the average LacZ ratio from triplicate
samples.
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induction of cmeABC by bile salts is mediated by release of the
repression imposed by cmeR on cmeABC. To determine if the
induction of cmeABC is fully CmeR dependent, the transcrip-
tion of cmeABC was also measured in the cmeR null mutant
(JL111) in the presence or absence of bile salts. Compared
with that in JL110 (CmeR positive), the transcription of
cmeABC in JL111 (CmeR negative) increased approximately
fivefold in MH broth without bile salts (Fig. 4). In the presence
of cholate, both JL110 and JL111 showed similar levels of
increase (approximately fivefold) in the transcription of
cmeABC, suggesting that the induction by cholate is fully
CmeR dependent. However, the transcription level of cmeABC
in JL110 in the presence of taurocholate exceeded that of the
cmeR null mutant (JL111) and addition of taurocholate in the
JL111 culture further enhanced the transcription of cmeABC
over that in JL110 with taurocholate (Fig. 4). Since the cmeR
null mutant displayed a fivefold increase in cmeABC transcrip-
tion, the additional increase beyond the fivefold change in
cmeABC transcription by taurocholate in JL110 and JL111 was
not attributable to the release of CmeR-mediated suppression
and suggests that a CmeR-independent pathway was also in-
volved in the induction by taurocholate. Recently, Raphael et
al. identified a Campylobacter response regulator (named
CbrR) that is involved in bile resistance (40). To determine if
CbrR was involved in the activation of cmeABC by bile salts,
we introduced the cbrR mutation into JL110. When examined
by the LacZ assay, the promoter activities of cmeABC were
comparable between JL110 and JL112, regardless of the
growth conditions (with or without cholate or taurocholate).
This result suggests that CbrR is not involved in the activation
of cmeABC in C. jejuni.
Bile salts increase resistance of Campylobacter to antibiotics.
Since bile salts induced the expression of the CmeABC efflux
system and CmeABC works synergistically with other mecha-
nisms in conferring antimicrobial resistance (21, 25), we sought
to determine if bile salts affected the susceptibility of Campy-
lobacter to antibiotics. For this purpose, we compared the
MICs of several antibiotics in strain 81-176 in the presence or
absence of bile salts. As shown in Table 2, the presence of
taurocholate in culture media resulted in a two- to fourfold
increase in the resistance of Campylobacter to structurally di-
vergent antibiotics, including cefotaxime, novobiocin, cipro-
floxacin, fusidic acid, and erythromycin. The presence of
cholate led to a twofold increase in MICs of some of the
antibiotics but did not cause any measurable MIC changes with
ciprofloxacin and erythromycin (Table 2). Consistent with the
findings that taurocholate induced a higher level of transcrip-
FIG. 3. SPR analysis of CmeR interaction with immobilized PcmeABC.
(A) CmeR (104 nM) was preincubated with sodium choleate at various
concentrations, including 0 g/ml (– –), 2 g/ml (F), 16 g/ml (■), and
125 g/ml (). The preincubated mixture (30 l) was injected at a flow
rate of 20 l/min. (B) Sodium choleate at 0 g/ml (– –), 2 g/ml (F),
16 g/ml (■), and 125 g/ml () was injected just after the association
phase by using the “co-inject” Biacore procedure. The arrow indicates
the time of injection of sodium choleate. Each experiment was repli-
cated at least three times, and all yielded similar results. This figure
shows the results from one representative experiment.
FIG. 4. CmeR-dependent and -independent induction of cmeABC
by bile salts. JL110 and JL111 grown in MH broth only or with 1 mg/ml
cholate (CA) or 12.5 mg/ml taurocholate (TCA) were used for the
LacZ assay. The genetic backgrounds and the culture conditions are
illustrated at the bottom. Each bar represents the mean LacZ activity

 standard deviation of triplicate samples.
TABLE 2. Effects of cholate (CA) and taurocholate (TCA) on the
susceptibility of C. jejuni 81-176 to antibiotics
Antibiotic
MIC (g/ml)a
No bile With CA(1 mg/ml)
With TCA
(25 mg/ml)
Cefotaxime 0.125 0.250 (2) 0.500 (4)
Novobiocin 16 32 (2) 64 (4)
Ciprofloxacin 0.0625 0.0625 (0) 0.125 (2)
Fusidic acid 64 128 (2) 256 (4)
Erythromycin 0.125 0.125 (0) 0.25 (2)
a The numbers in parentheses indicate the differences (n-fold) in MICs for
strain 81-176 grown in the absence and presence of the corresponding bile salt.
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tion of cmeABC than cholate did (Fig. 1 and 4), the MICs of
the antibiotics assayed in the presence of taurocholate are
reproducibly twofold higher than those in the presence of
cholate (Table 2). Although the MIC changes were moderate,
the results were reproducible in three independent experi-
ments. Given the fact that bile conjugates are naturally present
in animal intestinal tract, the results suggest that the presence
of bile salts in vivo may decrease the susceptibility of Campy-
lobacter to antibiotics.
DISCUSSION
Bacterial MDR pumps can be conditionally induced by their
substrates, including antibiotics (6, 10, 11, 24, 27, 28, 47). De-
spite the fact that MDR pumps play important roles in antibi-
otic resistance, efflux of antibiotics by these pumps is consid-
ered an opportunistic function of the pumps, and the natural
functions of the MDR efflux system are largely unknown (32,
35). Unlike antibiotics, natural antimicrobials such as bile salts
are ubiquitously present in animal hosts and form a formidable
barrier against invading bacteria in the intestinal tract. Thus,
enteric bacteria have evolved multiple mechanisms for adap-
tation to the bile-containing habitat (12, 20). One of the major
mechanisms involved in bile resistance is active efflux con-
ferred by various membrane transporters, particularly the
RND-type efflux pumps (22, 37, 48). In Campylobacter, inacti-
vation of the cmeB gene resulted in a drastic increase in bile
sensitivity and the cmeB null mutant was unable to colonize the
intestinal tracts of chickens (22). In E. coli, Salmonella, and
Vibrio cholerae, the AcrAB-TolC efflux pump (a homolog of
the CmeABC pump) contributes to bile resistance and is in-
ducible by bile salts (4, 37, 42). Given that bile acids are a
natural component in the intestinal environment, the accumu-
lating evidence on efflux-mediated bile resistance strongly sug-
gests that efflux of bile acids is the natural function of some
RND-type transporters (e.g., AcrAB-TolC and CmeABC) in
enteric bacteria.
In this study, compelling evidence to demonstrate that bile
salts modulate the production of CmeABC, a major efflux
mechanism in C. jejuni, is provided. This conclusion is based on
the facts that (i) transcription of cmeABC was greatly en-
hanced in the presence of various bile salts (Fig. 1 and 2), (ii)
the production of the CmeABC proteins was increased in
bile-containing media (Fig. 1), (iii) choleate inhibited CmeR
binding to PcmeABC (Fig. 3), releasing the repression on the
transcription of cmeABC, and (iv) bile salts increased the re-
sistance of C. jejuni to several antibiotics (Table 2), which
agrees with the finding that the efflux machinery is elevated by
bile salts. Since CmeABC is essential for bile resistance (22),
the inducible expression of cmeABC by bile salts provides a
flexible mechanism for Campylobacter to adapt in the intestinal
environment. This notion is further supported by a recent
study by Stintzi et al. (46), in which the expression of cmeABC
was found to be highly up-regulated in rabbit ileal loops, as
determined by whole-genome microarray. The elevated tran-
scription of cmeABC in the rabbit ileal loops was likely the
direct result of bile induction, although nonbile inducers for
cmeABC may also exist in the gut.
Findings from this study revealed several unique features of
CmeABC induction by bile salts in C. jejuni. First, expression
of cmeABC can be significantly induced by both conjugated
(e.g., taurocholate, glycocholate, and taurodeoxycholate) and
unconjugated (e.g., cholate, deoxycholate, and chenodeoxy-
cholate) bile salts. The major types of bile produced by the
liver are the taurine and glycine conjugates of cholic acid and
chenodeoxycholic acid, which are known as primary bile acids
(48). These primary bile acids are secreted into the intestine,
where deconjugation by residential microbes results in various
secondary bile acid metabolites (e.g., deoxycholic acid and
chenodeoxycholic acid). Thus, both conjugated and unconju-
gated bile salts exist in animal intestinal tract. In contrast to
induction of CmeABC, induction of AcrAB in E. coli was
obvious only with some unconjugated lipophilic bile salts (e.g.,
deoxycholate), while conjugated bile salts and other unconju-
gated bile salts (e.g., cholate) produced little or modest induc-
tion of AcrAB (42). In S. enterica serovar Typhimurium, tran-
scription of acrAB was inducible by bile, but it is unclear which
specific component of bile induces acrAB (37). However, de-
oxycholate was the only bile salt that activated transcription of
marRAB, an operon involved in multidrug resistance in E. coli
and Salmonella (37). Second, the magnitude of induction of
cmeABC by bile salts in C. jejuni was much greater than that of
acrAB in E. coli. Various bile salts at sublethal concentrations
produced a 6- to 16-fold (Fig. 1A) induction of cmeABC (Fig.
1), while only up to a 1.7-fold induction was observed with
acrAB in E. coli (42). Third, induction of cmeABC in C. jejuni
is clearly dose dependent and time dependent (Fig. 2). Since
CmeR is a cytoplasmic protein, intracellular accumulation of
bile salts is required to achieve the induction of cmeABC,
which may explain the time- and dose-dependent responses.
For E. coli and S. enterica serovar Typhimurium, it is not clear
if the induction of AcrAB by bile salts is kinetically similar to
that of cmeABC in Campylobacter. Another difference is that
growth phase affects the transcription of acrAB in E. coli and
S. enterica serovar Typhimurium (37, 42), while growth phase
had no effect on the transcription rate of cmeABC in Campy-
lobacter (data not shown). Thus, the time-dependent manner
of cmeABC induction by bile salts is unlikely an artifact caused
by growth phase.
The CmeABC efflux system is regulated by CmeR, a TetR
family repressor (19). The specific interaction between CmeR
and PcmeABC has been demonstrated in a previous study (19).
Since the classical gel mobility shift assay is not always appro-
priate for assessing the interaction between inducers and reg-
ulators (31, 42), we chose to measure the effect of bile salts on
CmeR binding to PcmeABC in a real-time manner by using SPR.
According to the data from the SPR experiments in this study,
the KD of CmeR to PcmeABC is 88 
 2 nM, which is in the same
range as that reported for EthR (KD  146 nM), another
repressor of the TetR/CamR family (8). By contrast, the affin-
ities of MexL and CamR to their corresponding target pro-
moters were low, with KD values of 900 nM and 1,500 nM,
respectively (1, 5). However, the KD values of MexL and CamR
were determined by gel mobility shift assays, instead of by SPR.
According to the KD values, the affinity of CmeR to PcmeABC is
substantially lower than that of TetR (KD  0.2 nM) to tetO
(16). The difference in the KD values is in agreement with
previous findings showing that TetR tightly represses the tetO
operator in the absence of tetracycline (33), while the cmeABC
efflux pump is constitutively expressed at a moderate level in
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spite of the repression by CmeR (19, 21, 34), suggesting a
relatively loose control of cmeABC by CmeR.
The results from the SPR experiments (Fig. 3) also demon-
strated that bile salts interfere with the binding of CmeR to
PcmeABC and promote the dissociation of CmeR from the im-
mobilized PcmeABC. This finding is consistent with the in vivo
induction of cmeABC expression by bile salts (Fig. 1 and 2) and
strongly suggests that bile-mediated inhibition of CmeR bind-
ing to PcmeABC is responsible for the enhanced transcription of
cmeABC. Transcriptional regulators of the TetR family are
characterized by a conserved HTH-containing DNA-binding
domain at the N-terminal region and a divergent C-terminal
sequence that is involved in binding to various inducing ligands
(11, 14, 15). Binding by an inducing compound to the C-
terminal region triggers conformational changes in the N-ter-
minal DNA-binding domain, reducing the affinity of a regula-
tor to its target promoter DNA (10). Such structural changes in
a repressor induced by the binding of a ligand have been
confirmed for several regulator proteins in the TetR family,
such as TetR and QacR (33, 44). Similar to other TetR family
regulators, CmeR has a typical N-terminal DNA-binding HTH
motif and a potential ligand-binding region in the C-terminal
portion. Therefore, it is likely that bile salts interact with the
C-terminal region of CmeR and induce conformational
changes in the repressor, resulting in a great reduction in its
DNA binding affinity. This speculation is in agreement with the
results obtained from this study and needs to be confirmed by
crystallization of the complex formed by CmeR and its induc-
ing ligands. The real-time PCR result from this study indicated
that transcription of cmeR was not affected by bile salts (data
not shown), suggesting that the promoter activity of cmeR is
not influenced by bile. Hence, altered expression of cmeR is
not likely a factor in the induction of cmeABC by bile salts.
One of the interesting findings of this study is that both
CmeR and a CmeR-independent pathway are involved in the
induction of cmeABC. It appears that the induction by cholate
is fully CmeR dependent, because both JL110 (with CmeR)
and JL111 (without CmeR) showed similar levels of cmeABC
transcription in the presence of cholate (Fig. 4). However,
taurocholate further enhanced cmeABC transcription in the
absence of a functional CmeR (Fig. 4), suggesting that a
CmeR-independent pathway is also involved in the induction
of cmeABC by taurocholate. It is possible that some bile salts
(e.g., taurocholate) regulate another uncharacterized protein
that subsequently activates the transcription of cmeABC. This
hypothesis is conceivable because bile salts are known to in-
fluence the expression of multiple genes in bacterial cells and
because multiple sensing mechanisms (including two-compo-
nent systems) are involved in bacterial resistance to bile (3, 13,
20, 37, 43, 49). Recently, Raphael et al. (40) identified a re-
sponse regulator (named CbrR) that is involved in bile resis-
tance in C. jejuni. Inactivation of cbrR did not affect the induc-
tion of cmeABC by bile (data not shown), suggesting that CbrR
is not involved in the activation of cmeABC. In E. coli, the
major MDR efflux pump AcrAB is negatively regulated by the
local repressor AcrR but positively regulated by global activa-
tors, including MarA, SoxS, and Rob (18). At this stage, it is
unclear which regulator is involved in the CmeR-independent
activation of cmeABC and how it modulates cmeABC expres-
sion in response to bile.
In summary, findings from this study revealed an induction-
based mechanism that modulates the expression of cmeABC in
response to bile salts, an environmental signal naturally occur-
ring in the intestinal tract. This new finding plus previously
identified roles of CmeABC in bile resistance and Campy-
lobacter colonization highlight the significance of CmeABC in
Campylobacter adaptation to the intestinal environment in an-
imal hosts. Notably, in the presence of bile salts, Campylobacter
showed increased resistance to several antibiotics due to over-
expression of CmeABC (Table 2). Although the enhanced
efflux itself cannot confer clinically relevant resistance to anti-
biotics, it may facilitate bacteria to better survive selection
pressure and promote the emergence of antibiotic-resistant
mutants via target gene mutations (e.g., gyrA mutations medi-
ating fluoroquinolone resistance). This speculation is consis-
tent with the observation that ciprofloxacin-resistant Campy-
lobacter rapidly emerged in the intestinal tracts of chickens or
humans treated with fluoroquinolone antimicrobials (25, 29,
45, 52). However, direct evidence is still lacking for bile-medi-
ated enhancement of antimicrobial resistance in vivo. Thus,
whether bile-induced expression of cmeABC influences the
emergence of antibiotic-resistant Campylobacter in vivo re-
mains to be examined in future studies.
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